House Bill 70, sponsored by Helton-Haynes, amends Tennessee law to require coverage and reimbursement for biomarker testing for preeclampsia under TennCare health benefit plans issued or renewed on or after July 1, 2025. The bill defines key terms related to biomarker testing, including "biomarker," "biomarker test," and "health benefit plan," and stipulates that a pregnant woman may undergo biomarker testing for preeclampsia when ordered by her attending physician. The testing must be conducted according to nationally recognized clinical practice guidelines.

Additionally, the bill empowers the division of TennCare to establish rules and take necessary administrative actions to implement this coverage, ensuring compliance with the Uniform Administrative Procedures Act. It also allows the division to submit new waiver applications or amendments to existing waivers to secure federal financial participation for Medicaid coverage related to biomarker testing for preeclampsia. The act will take effect immediately for rulemaking purposes, while the coverage provisions will be effective starting July 1, 2025.